"Glück auf! Das Evangelische Klinikum Gelsenkirchen. Das Leben im Ruhrgebiet ist vielfältig: bunt, offen, herzlich, manchmal aber auch hektisch und mit Strapazen verbunden. Umso wichtiger ist es, bei Erkrankungen den ganzheitlichen Blick auf Körper und Seele der Patientin oder des Patienten zu wahren. Als Evangelische Kliniken Gelsenkirchen fühlen wir uns diesem Grundsatz gegenüber den Menschen unserer einzigartigen Region verpflichtet – und tun alles, um ihm gerecht zu werden. Mit medizinischer Fachkenntnis, modernster Technologie und engagierter Pflege. Als akademisches Lehrkrankenhaus der Universität Duisburg-Essen bilden wir zudem Medizinerinnen und Mediziner von morgen aus."

During the past decade, Evangelische Kliniken Gelsenkirchen conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelische Kliniken Gelsenkirchen" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Evangelische Kliniken Gelsenkirchen" are "Early Stage Breast Cancer" (1 trials), "HER2-Positive Primary Breast Cancer" (1 trials), "Primary Breast Cancer AR+ve TNBN" (1 trials), "Primary Breast Cancer ER+ve" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Evangelische Kliniken Gelsenkirchen" in a lesser frequency.

Most popular intervention types in "Evangelische Kliniken Gelsenkirchen" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DS-8201a" (1 trials), "Enzalutamide" (1 trials), "Exemestane" (1 trials), "Not suitable for TAD" (1 trials) and "Suitable for TAD" (1 trials). Other intervention names were less common.

The vast majority of trials in "Evangelische Kliniken Gelsenkirchen" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Evangelische Kliniken Gelsenkirchen". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Evangelische Kliniken Gelsenkirchen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Evangelische Kliniken Gelsenkirchen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".